MedTrace Logo

Discontinuation Order of Vasopressors in Septic Shock

NCT01493102 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2015-01-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate the incidence of hypotension based on the discontinuation order of norepinephrine and vasopressin in patients receiving concomitant norepinephrine and vasopressin infusions for the treatment of septic shock.

Conditions

  • Septic Shock

Interventions

DRUG

Vasopressin

Vasopressin will be reduced first (0.01 U/hour)

DRUG

Norepinephrine

Norepinephrine will be reduced first (0.1 microgram/kg/hour)

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • kyeongman Jeon, M.D., Ph.D. · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01493102 on ClinicalTrials.gov